Bloks Group Limited — Earnings Release 2004

Jan 16, 2004

Listed Company Information

HK PHARMA<00182> - Results Announcement Hong Kong Pharmaceutical Holdings Limited announced on 16/1/2004: (stock code: 00182 ) Year end date: 31/3/2004 Currency: HKD Auditors' Report: N/A Interim report reviewed by: Audit Committee (Unaudited ) (Unaudited ) Last Current Corresponding Period Period from 1/4/2003 from 1/4/2002 to 30/9/2003 to 30/9/2002 Note ('000 ) ('000 ) Turnover : 60,669 49,806 Profit/(Loss) from Operations : (6,461) (27,273) Finance cost : (3,325) (3,527) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A Profit/(Loss) after Tax & MI : (8,332) (23,193) % Change over Last Period : N/A % EPS/(LPS)-Basic (in dollars) : (0.0059) (0.0168) -Diluted (in dollars) : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : (8,332) (23,193) Interim Dividend : NIL NIL per Share (Specify if with other : N/A N/A options) B/C Dates for Interim Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1. LOSS PER SHARE The calculation of basic loss per share is based on the net loss from ordinary activities attributable to shareholders for the period of approximately HK$8,332,000 (2002: approximately HK$23,193,000), and the weighted average number of 1,403,796,698 (2002: 1,383,629,485) ordinary shares in issue during the period. Diluted loss per share amounts for the six months ended 30 September 2003 and 2002 have not been presented because the effects of the assumed conversion of the share options and convertible notes of the Company during these periods were anti-dilutive. 2. DIVIDEND The Directors do not recommend the payment of any interim dividend for the six months ended 30 September 2003 (2002:Nil).